130 related articles for article (PubMed ID: 12556212)
1. Novel agents and strategies to treat herpes simplex virus infections.
Kleymann G
Expert Opin Investig Drugs; 2003 Feb; 12(2):165-83. PubMed ID: 12556212
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis.
Quenelle DC; Birkmann A; Goldner T; Pfaff T; Zimmermann H; Bonsmann S; Collins DJ; Rice TL; Prichard MN
Antiviral Res; 2018 Jan; 149():1-6. PubMed ID: 29113740
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy.
Bacon TH; Levin MJ; Leary JJ; Sarisky RT; Sutton D
Clin Microbiol Rev; 2003 Jan; 16(1):114-28. PubMed ID: 12525428
[TBL] [Abstract][Full Text] [Related]
4. Intermittent therapy with helicase-primase inhibitor IM-250 efficiently controls recurrent herpes disease and reduces reactivation of latent HSV.
Bernstein DI; Sawtell NM; Bravo FJ; Dixon DA; Gege C; Kleymann G
Antiviral Res; 2023 Nov; 219():105733. PubMed ID: 37858763
[TBL] [Abstract][Full Text] [Related]
5. Antiviral Agents for the Prevention and Treatment of Herpes Simplex Virus Type-1 Infection in Clinical Oncology: A Network Meta-Analysis.
Aribi Al-Zoobaee FW; Yee Shen L; Veettil SK; Gopinath D; Maharajan MK; Menon RK
Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33265920
[TBL] [Abstract][Full Text] [Related]
6. Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses.
Aoki FY
Can J Infect Dis; 2003 Jan; 14(1):17-27. PubMed ID: 18159421
[TBL] [Abstract][Full Text] [Related]
7. Anti herpes simplex virus activity of lactoferrin/lactoferricin -- an example of antiviral activity of antimicrobial protein/peptide.
Jenssen H
Cell Mol Life Sci; 2005 Dec; 62(24):3002-13. PubMed ID: 16261265
[TBL] [Abstract][Full Text] [Related]
8. Effects of antiviral usage on transmission dynamics of herpes simplex virus type 1 and on antiviral resistance: predictions of mathematical models.
Lipsitch M; Bacon TH; Leary JJ; Antia R; Levin BR
Antimicrob Agents Chemother; 2000 Oct; 44(10):2824-35. PubMed ID: 10991866
[TBL] [Abstract][Full Text] [Related]
9. Anti-herpes simplex virus activities and mechanisms of marine derived compounds.
Hao C; Xu Z; Xu C; Yao R
Front Cell Infect Microbiol; 2023; 13():1302096. PubMed ID: 38259968
[TBL] [Abstract][Full Text] [Related]
10. Antibody-based concepts for multipurpose prevention technologies.
Whaley KJ; Zeitlin L
Antiviral Res; 2013 Dec; 100 Suppl(0):S48-53. PubMed ID: 24188703
[TBL] [Abstract][Full Text] [Related]
11. Development of Provesicular Nanodelivery System of Curcumin as a Safe and Effective Antiviral Agent: Statistical Optimization, In Vitro Characterization, and Antiviral Effectiveness.
Badria FA; Abdelaziz AE; Hassan AH; Elgazar AA; Mazyed EA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33271831
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the therapeutic potential of homeopathic medicine Rhus Tox for herpes simplex virus and inflammatory conditions.
Shinde MD; Patil SA; Mukherjee A; Nema V
J Ayurveda Integr Med; 2023; 14(4):100739. PubMed ID: 37421729
[TBL] [Abstract][Full Text] [Related]
13. Update on new antivirals under development for the treatment of double-stranded DNA virus infections.
Dropulic LK; Cohen JI
Clin Pharmacol Ther; 2010 Nov; 88(5):610-9. PubMed ID: 20881959
[TBL] [Abstract][Full Text] [Related]
14. Symptomatic Herpes Simplex Virus Infection and Risk of Dementia in US Veterans: a Cohort Study.
Young-Xu Y; Powell EI; Zwain GM; Yazdi MT; Gui J; Shiner B
Neurotherapeutics; 2021 Oct; 18(4):2458-2467. PubMed ID: 34244925
[TBL] [Abstract][Full Text] [Related]
15. Herpes Infections and Dementia: Rebutting Alternative Fact.
Lathe R; Tzeng NS; Itzhaki R
Neurotherapeutics; 2019 Jan; 16(1):176-179. PubMed ID: 30617654
[TBL] [Abstract][Full Text] [Related]
16. Treatment of herpes simplex virus infections.
Brady RC; Bernstein DI
Antiviral Res; 2004 Feb; 61(2):73-81. PubMed ID: 14670580
[TBL] [Abstract][Full Text] [Related]
17. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
Schuhmacher A; Reichling J; Schnitzler P
Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235
[TBL] [Abstract][Full Text] [Related]
18. [Development of antiviral therapeutic agents from traditional medicines].
Namba T; Kurokawa M; Kadota S; Shiraki K
Yakugaku Zasshi; 1998 Sep; 118(9):383-400. PubMed ID: 9778999
[TBL] [Abstract][Full Text] [Related]
19. Essential Oils for the Treatment of Herpes Simplex Virus Infections.
Schnitzler P
Chemotherapy; 2019; 64(1):1-7. PubMed ID: 31234166
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of essential oils against herpes simplex virus type 2.
Koch C; Reichling J; Schneele J; Schnitzler P
Phytomedicine; 2008 Jan; 15(1-2):71-8. PubMed ID: 17976968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
